Tuesday, April 26, 2011
New NIH Council of Councils members named
The National Institutes of Health today announced the appointments of 20 individuals to the NIH Council of Councils. The council was established by the NIH Reform Act of 2006 to advise the NIH Director on cutting edge, trans-NIH priorities and matters related to policies and activities of the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), also established by the act.
The council is made up of 27 members selected from the NIH Institute and Center (IC) advisory councils and the Council of Public Representatives, an advisory committee to the NIH Office of the Director. Council members bring their knowledge of their individual ICs' missions and operations, not as official representatives, but to provide advice beyond the research agenda of any one IC.
"The wealth of expertise brought by these individuals will enhance the council's ability to achieve its mission by offering a diversity of perspectives and talents. Collectively the council will inform our approach to broad research initiatives shared across NIH and not limited to a single IC." said DPCPSI Director, James M. Anderson, M.D., Ph.D.
The following are serving terms on the council (all terms end Oct. 31 of the year in parentheses):
Stephen L. Barnes, Ph.D., University of Alabama at Birmingham, nominated by the National Center for Complementary and Alternative Medicine (2012)
Jordan M. Cohen, M.D., The George Washington University, Washington, D.C., nominated by the National Library of Medicine (2011)
Elizabeth B. Concordia, M.A.S., University of Pittsburgh Medical Center, nominated by the NIH Clinical Center (2012)
David W. Crabb, M.D., Indiana University School of Medicine, Indianapolis, nominated by the National Institute on Alcohol Abuse and Alcoholism (2012)
Richard L. Ehman, M.D., Mayo Clinic College of Medicine, Rochester, Minn., nominated by the National Institute of Biomedical Imaging and Bioengineering (2013)
Jack A. Elias, M.D., Yale University School of Medicine, New Haven, Conn., nominated by the National Heart Lung, and Blood Institute (2013)
Garret FitzGerald, M.D., University of Pennsylvania, Philadelphia, nominated by the Center for Scientific Review (2013)
Daniel H. Geschwind, M.D., Ph.D., David Geffen School of Medicine, University of California, Los Angeles, nominated by the National Institute of Mental Health (2012)
Mae O. Gordon, Ph.D., Washington University School of Medicine, St. Louis, nominated by the National Eye Institute (2012)
Peter J. Hotez, M.D., Ph.D., Sabin Vaccine Institute and The George Washington University, Washington, D.C., nominated by the Fogarty International Center (2013)
Mark O. Lively, Ph.D., Wake Forest University School of Medicine, Winston-Salem, N.C., nominated by the National Center for Research Resources (2013)
Herbert Kim Lyerly, M.D., Duke University Medical Center, Durham, N.C., nominated by the National Cancer Institute (2013)
Jean McSweeney, Ph.D., R.N., University of Arkansas Medical Sciences, College of Nursing, Fayetteville, nominated by the National Institute of Nursing Research (2012)
Regis O’Keefe, M.D., Ph.D., University of Rochester School of Medicine, Rochester, N.Y., nominated by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (2013)
Regina Rabinovich, M.D., Bill and Melinda Gates Foundation, Seattle, nominated by the National Institute of Allergy and Infectious Diseases (2013)
David Valle, M.D., The Johns Hopkins University School of Medicine, Baltimore, nominated by the National Human Genome Research Institute (2012)
John W. Walsh, Alpha-1 Foundation, Miami, nominated by the Council of Public Representatives (2012)
Gary L. Westbrook, M.D., The Vollum Institute, Oregon Health and Science University, Portland, Ore., nominated by the National Institute of Neurological Diseases and Stroke (2012)
Terrie Fox Wetle, Ph.D., Brown University Medical School, Providence, R.I., nominated by the National Institute on Aging (2013)
Luther Williams, Ph.D., Tuskegee University, Ala., nominated by the National Center on Minority Health and Health Disparities (2012)
A roster with further information about the members is posted on the Council's website (http://dpcpsi.nih.gov/council/).
The Division of Program Coordination, Planning, and Strategic Initiatives, in the Office of the Director, NIH, identifies emerging scientific opportunities, rising public health challenges, and scientific knowledge gaps that merit further research. The Division plans and implements trans-NIH initiatives supported by the Common Fund and coordinates research related to AIDS, behavioral and social sciences, women's health, and disease prevention. Additional information about the Division can be found at: http://dpcpsi.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
NIH...Turning Discovery Into Health ®